JNJ
JOHNSON & JOHNSON · Healthcare · Market cap $621.2B
Insiders sold $70.2M net in the last 90 days ·6 sellers, 0 buyers· latest Form 4 filed Sep 4, 2026
Insider Buying
$258K
reported purchases (SEC code P)
Insider Selling
$150.7M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Sep 4, 2026
Schmid Timothy
JOHNSON & JOHNSON (JNJ) has 27 SEC Form 4 filings (142 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Sep 4, 2026.
Inside the rolling window, 11 insiders at JOHNSON & JOHNSON reported 1 open-market purchase totaling $258K and 16 open-market sales totaling $150.7M. The most active filer is EVP, WW Chair, MedTech Schmid Timothy with 3 filings. Insiders have net sold $70.2M over the trailing 6 months. The most recent open-market filing is a sale of 33,597 shares by EVP, WW Chair, MedTech Schmid Timothy, dated Sep 2, 2026, worth $9.2M.
- Industry:Drug Manufacturers - General
- CEO:Joaquin Duato
- Employees:141,700
- HQ:New Brunswick, NJ, US
- IPO:1962-01-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Schmid TimothyFirst in 6 months | EVP, WW Chair, MedTech | Sale | 33,597 | $9.2M | Sep 4 | -6.3% | SEC ↗ |
Taubert Jennifer LFirst filing | EVP, WWC. Innovative Medicine | Sale | 15,000 | $4.0M | Aug 18 | -4.9% | SEC ↗ |
| CEO and Chairman of the Board | Sale | 123,291 | $32.2M | Aug 14 | -1.0% | SEC ↗ | |
Duato JoaquinFirst in 6 months | CEO and Chairman of the Board | Sale | 48,480 | $12.5M | Aug 7 | -0.6% | SEC ↗ |
Forminard ElizabethFirst filing | EVP, Chief Legal Officer | Sale | 15,918 | $4.1M | Aug 7 | -0.6% | SEC ↗ |
Broadhurst VanessaFirst in 5 months | EVP, Global Corp Affairs | Sale | 23,054 | $5.8M | Jul 21 | +2.9% | SEC ↗ |
Wengel Kathryn EFirst filing | EVP, Chief TO and Risk Officer | Sale | 10,000 | $2.4M | Jun 12 | — | SEC ↗ |
Decker Robert JFirst filing | VP Corporate Controller | Sale | 4,075 | $1.0M | Mar 3 | — | SEC ↗ |
| EVP, WW Chair, MedTech | Sale | 1,322 | $325K | Feb 23 | — | SEC ↗ | |
| Exec VP, CFO | Sale | 89,654 | $21.8M | Feb 18 | — | SEC ↗ | |
Swanson James D.First filing | EVP, CIO | Sale | 41,559 | $10.1M | Feb 18 | — | SEC ↗ |
Swanson James D.First filing | EVP, CIO | Sale | 20,521 | $5.0M | Feb 18 | — | SEC ↗ |
REED JOHN CFirst filing | EVP, Innovative Medicine, R&D | Sale | 53,931 | $13.1M | Feb 18 | — | SEC ↗ |
Schmid TimothyFirst filing | EVP, WW Chair, MedTech | Sale | 22,623 | $5.5M | Feb 18 | — | SEC ↗ |
Broadhurst VanessaFirst filing | EVP, Global Corp Affairs | Sale | 6,197 | $1.5M | Feb 18 | — | SEC ↗ |
Duato JoaquinFirst filing | CEO and Chairman of the Board | Sale | 100,000 | $22.1M | Jan 28 | — | SEC ↗ |
MORIKIS JOHN GFirst filing | Director | Purchase | 1,250 | $258K | Dec 1 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading JNJ 289 all-time
- DRep. Lloyd DoggettPurchase$1,001 - $15,0002026-09-08
- RRep. Thomas H. KeanSale$1,001 - $15,0002026-08-27
- RSen. John BoozmanSale$1,001 - $15,0002026-08-20
- RSen. John BoozmanOther$1,001 - $15,0002026-08-20
- DRep. Ro KhannaSale$1,001 - $15,0002026-08-07
- RRep. Rich McCormickSale$1,001 - $15,0002026-07-30
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does JNJ have?
JOHNSON & JOHNSON (JNJ) has 27 SEC Form 4 filings (142 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Sep 4, 2026.
When was the most recent SEC Form 4 filing for JNJ?
The most recent Form 4 filing for JNJ on Tracefour is dated Sep 4, 2026.
Who is the most active insider at JNJ?
The most active SEC Form 4 filer at JNJ in the rolling window is EVP, WW Chair, MedTech Schmid Timothy, with 3 filings.
What is the net insider flow at JNJ over the last 6 months?
Over the trailing 180 days, insiders at JNJ have net sold $70.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at JNJ in the current window?
Inside the rolling window, insiders at JNJ bought $258K and sold $150.7M based on SEC Form 4 filings.
Can I get alerts for JNJ insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at JOHNSON & JOHNSON (JNJ). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
JOHNSON & JOHNSON is in the Healthcare sector.